BMB Reports

생화학분자생물학회 (Korean Society for Biochemistry and Molecular Biology)
권호 표지
DOI QR코드

DOI QR Code

A New Approach to Managing Oral Manifestations of Sjogren's Syndrome and Skin Manifestations of Lupus

  • Hsu, Stephen (Department of Oral Biology and Maxillofacial Pathology, School of Dentistry, Medical College of Georgia) ;
  • Dickinson, Douglas (Department of Oral Biology and Maxillofacial Pathology, School of Dentistry, Medical College of Georgia)
  • 투고 : 2006.03.29
  • 발행 : 2006.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Sj$\"{o}$gren's syndrome (SS) is an autoimmune disorder that affects the salivary glands, leading to xerostomia, and the lacrimal glands, resulting in xerophthalmia. Secondary SS is associated with other autoimmune disorders such as systemic rheumatic diseases and systemic lupus erythematosis (SLE), which can affect multiple organs, including the epidermis. Recent studies have demonstrated that green tea polyphenols (GTPs) possess both anti-inflammatory and anti-apoptotic properties in normal human cells. Epidemiological evidence has indicated that, in comparison to the United States, the incidence of SS, clinical xerostomia and lupus is considerably lower in China and Japan, the two leading green tea-consuming countries. Thus, GTPs might be responsible, in part, for geographical differences in the incidence of xerostomia by reducing the initiation or severity of SS and lupus. Consistent with this, molecular, cellular and animal studies indicate that GTPs could provide protective effects against autoimmune reactions in salivary glands and skin. Therefore, salivary tissues and epidermal keratinocytes could be primary targets for novel therapies using GTPs. This review article evaluates the currently available research data on GTPs, focusing on their potential application in the treatment of the oral manifestations of SS and skin manifestations of SLE.

키워드

참고문헌

  1. Afaq, F., Ahmad, N. and Mukhtar, H. (2003) Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 22, 9254-9264 https://doi.org/10.1038/sj.onc.1207035
  2. Ahmed, S., Wang, N., Lalonde, M., Goldberg, V. M. and Haqqi, T. M. (2004) Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J. Pharmacol. Exp. Ther. 308, 767-773
  3. Ahn, S. C., Kim, G. Y., Kim, J. H., Baik, S. W., Han, M. K., Lee, H. J., Moon, D. O., Lee, C. M., Kang, J. H., Kim, B. H., Oh, Y. H. and Park, Y. M. (2004) Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NFkappaB. Biochem. Biophys. Res. Commun. 313, 148-155 https://doi.org/10.1016/j.bbrc.2003.11.108
  4. Aktas, O., Prozorovski, T., Smorodchenko, A., Savaskan, N. E., Lauster, R., Kloetzel, P. M., Infante-Duarte, C., Brocke, S. and Zipp, F. (2004) Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol. 173, 5794-5800 https://doi.org/10.4049/jimmunol.173.9.5794
  5. Albert, M. L., Sauter, B. and Bhardwaj, N. (1998) Dendritic cells acquire antigen from apoptotic cells and induce class Irestricted CTLs. Nature 392, 86-89 https://doi.org/10.1038/32183
  6. Angotti, C. (2004) Immunology of cutaneous lupus erythematosus. Clin. Dermatol. 22, 105-112 https://doi.org/10.1016/j.clindermatol.2003.12.017
  7. Amoura, Z., Combadiere, C., Faure, S., Parizot, C., Miyara, M., Raphael, D., Ghillani, P., Debre, P., Piette, J. C. and Gorochov, G. (2003) Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Arthritis Rheum. 48, 3487-3496 https://doi.org/10.1002/art.11350
  8. Aringer, M. and Smolen, J. S. (2004) Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus. 13, 344-347 https://doi.org/10.1191/0961203303lu1024oa
  9. Azuma, M., Tamatani, T., Kasai, Y. and Sato, M. (1993) Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori- mutant deoxyribonucleic acid. Lab. Invest. 69, 24-42
  10. Banerjee, R. K. and Datta, A. G. (1986) Salivary peroxidases. Mol. Cell. Biochem. 70, 21-29
  11. Baudouin, C., Pisella, P. J. and Brignole, F. (2004) Current treatments of xerophthalmia in Sjögren's syndrome. Rev. Med. Interne. 25, 376-382 https://doi.org/10.1016/j.revmed.2003.10.009
  12. Billings, R. J., Proskin, H. M. and Moss, M. E. (1996) Xerostomia and associated factors in a community-dwelling adult population. Commun. Dent. Oral Epidemiol. 24, 312-316 https://doi.org/10.1111/j.1600-0528.1996.tb00868.x
  13. Bollain-y-Goytia, J. J., Avalos-Diaz, E. and Herrera-Esparza, R. (2000) Fas ligand and Bax gene transcription contributes to Ro60 ribonucleoprotein redistribution in UV-A irradiated human keratinocytes. Joint Bone Spine. 67, 283-289
  14. Bolstad, A. I. and Jonsson, R. (2002) Genetic aspects of Sjögren's syndrome. Arthritis Res. 4, 353-359 https://doi.org/10.1186/ar599
  15. Brautigam, V. M., Frasier, C., Nkodemova, M. and Watters, J. J. (2005) Purinergic receptor modulation of BV-2 microglial cell activity: Potential involvement of p38 MAP kinase and CREB. J. Neuroimmunol. 166, 113-125 https://doi.org/10.1016/j.jneuroim.2005.05.012
  16. Bredberg, A., Henriksson, G., Larsson, A., Manthorpe, R. and Sallmyr, A. (2005) Sjogren's syndrome and the danger model. Rheumatology 44, 965-970 https://doi.org/10.1093/rheumatology/keh647
  17. Callen, J. P. (2004) Update on the management of cutaneous lupus erythematosus. Br. J. Dermatol. 151, 731-736 https://doi.org/10.1111/j.1365-2133.2004.06196.x
  18. Caricchio, R., McPhie, L. and Cohen, P. L. (2003) Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J. Immunol. 171, 5778-5786 https://doi.org/10.4049/jimmunol.171.11.5778
  19. Carsons, S. (2001) A review and update of Sjogren's syndrome: manifestations, diagnosis, and treatment. Am. J. Manag. Care. 7, 433-443
  20. Casciola-Rosen, L. A., Anhalt, G. J. and Rosen, A. (1995) DNAdependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182, 1625-1634 https://doi.org/10.1084/jem.182.6.1625
  21. Casciola-Rosen, L. A., Anhalt, G. and Rosen, A. (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330 https://doi.org/10.1084/jem.179.4.1317
  22. Cassolato, S. F. and Turnbull, R. S. (2003) Xerostomia: clinical aspects and treatment. Gerodontology 20, 64-77 https://doi.org/10.1111/j.1741-2358.2003.00064.x
  23. CDC Office of Communication (OC), 2002
  24. Cha, S., Peck, A. B. and Humphreys-Beher, M. G. (2002) Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update. Crit. Rev. Oral Biol. Med. 13, 4-16 https://doi.org/10.1177/154411130201300102
  25. Chaudhry, S. I., Murphy, L. A. and White, I. R. (2005) Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis? Clin. Exp. Dermatol. 30, 655-658 https://doi.org/10.1111/j.1365-2230.2005.01900.x
  26. Clark-Lewis, I., Mattioli, I., Gong, J. H. and Loetscher, P. (2003) Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J. Biol. Chem. 278, 289-295 https://doi.org/10.1074/jbc.M209470200
  27. Cravens, P. D. and Lipsky, P. E. (2002) Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol. Cell Biol. 80, 497-505 https://doi.org/10.1046/j.1440-1711.2002.01118.x
  28. Curtis, C. L., Harwood, J. L., Dent, C. M. and Caterson, B. (2004) Biological basis for the benefit of nutraceutical supplementation in arthritis. Drug Discov. Today 9, 165-172 https://doi.org/10.1016/S1359-6446(03)02980-5
  29. Daniels, T. E. (2000) Evaluation, differential diagnosis, and treatment of xerostomia. J. Rheumatol. Suppl. 61, 6-10
  30. Daniels, T. E. and Fox, P. C. (1992) Salivary and oral components of Sjogren's syndrome. Rheum. Dis. Clin. North Am. 18, 571- 589
  31. Daniels, F. J. (1961) Histochemical responses of human skin following ultraviolet radiation. J. Invest. Dermatol. 37, 351- 356 https://doi.org/10.1038/jid.1961.58
  32. Daniels, T. E. and Wu, A. J. (2000) Xerostomia--clinical evaluation and treatment in general practice. J. Calif Dent Assoc. 28, 933-941
  33. Dent, P., Yacoub, A., Fisher, P. B., Hagan, M. P. and Grant, S. (2003) MAPK pathways in radiation responses. Oncogene 22, 5885-5896 https://doi.org/10.1038/sj.onc.1206701
  34. Elmets, C. A., Singh, D., Tubesing, K., Matsui, M., Katiyar, S. and Mukhtar, H. (2001) Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J. Am. Acad. Dermatol. 44, 425-432 https://doi.org/10.1067/mjd.2001.112919
  35. Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P. and Jahnsen, F. L. (2001) Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159, 237-243 https://doi.org/10.1016/S0002-9440(10)61689-6
  36. Frei, B. and Higdon, J. V. (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J. Nutr. 133, 3275-3284 https://doi.org/10.1093/jn/133.10.3275S
  37. Fox, P. C. (2004) Salivary enhancement therapies. Caries Res. 38, 241-246 https://doi.org/10.1159/000077761
  38. Fox, R. I. (1997) Sjogren's syndrome. Controversies and progress. Clin. Lab Med. 17, 431-444
  39. Fox, R. I. (2003) Sjogren's syndrome: evolving therapies. Expert Opin. Investig Drugs. 12, 247-254 https://doi.org/10.1517/13543784.12.2.247
  40. Furukawa, F., Kashihara-Sawami, M., Lyons, M. B. and Norris, D. A. (1990) Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J. Invest. Dermatol. 94, 77-85 https://doi.org/10.1111/1523-1747.ep12873930
  41. Furukawa, F., Itoh, T., Wakita, H., Yagi, H., Tokura, Y., Norris, D. A. and Takigawa, M. (1999) Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin. Exp. Immunol. 118, 164-170 https://doi.org/10.1046/j.1365-2249.1999.01026.x
  42. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K. and Leto, T. L. (2003) Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17, 1502-1504 https://doi.org/10.1096/fj.02-1104fje
  43. Gerl, V., Hostmann, B., Johnen, C., Waka, A., Gerl, M., Schumann, F., Klein, R., Radbruch, A. and Hiepe, F. (2005) The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I. Arthritis Rheum. 52, 531-538 https://doi.org/10.1002/art.20851
  44. Green tea. (2000) Altern Med Rev. 5, 372-375
  45. Golan, T. D. Elkon, K. B. Gharavi, A. E. and Krueger, J. G. (1992) Enhanced membrane binding of auto antibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J. Clin. Invest. 90, 1067-1076 https://doi.org/10.1172/JCI115922
  46. Haqqi, T. M., Anthony, D. D., Gupta, S., Ahmad, N., Lee, M. S., Kumar, G. K. and Mukhtar, H. (1999) Prevention of collageninduced arthritis in mice by a polyphenolic fraction from green tea. Proc. Natl. Acad. Sci. USA 96, 4524-4529
  47. Hayashi, Y., Arakaki, R. and Ishimaru, N. (2003) The role of caspase cascade on the development of primary Sjogren's syndrome. J. Med. Invest. 50, 32-38
  48. Hayashi, Y., Arakaki, R. and Ishimaru, N. (2004) Apoptosis and estrogen deficiency in primary Sjögren's syndrome. Curr. Opin Rheumatol. 16, 522-526 https://doi.org/10.1097/01.bor.0000135450.78047.78
  49. Hsu, S., Green Tea and the Skin (2005) J. Am. Acad. Dermatol. 52, 1049-1059 https://doi.org/10.1016/j.jaad.2004.12.044
  50. HHS Office of Minoirty Health Resource Center (OMHRC), 2001
  51. Hsu, S., Bollag, W.B., Lewis, J., Huang, Q., Singh, B., Sharawy, M., Yamamoto, T. and Schuster, G. (2003) Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes. J. Pharmacol. Exp. Ther. 306, 29-34 https://doi.org/10.1124/jpet.103.049734
  52. Hsu, S., Dickinson, D., Qin, H., Lapp, C., Lapp, D., Borke, J., Walsh, D. S., Bollag, W. B, Stoppler, H., Yamamoto, T., Osakai, T. and Schuster, G. (2005) Inhibition of autoantigen expression by (-)-epigallocatechin-3-gallate (the major constituent of green tea) in normal human cells. J. Pharmacol. Exp. Ther. 315, 805-811 https://doi.org/10.1124/jpet.105.090399
  53. Hsu, S., Dichinson, D. P., Qin, H., Borke, J. L., Ogbureke, K., Sharawy, M., Camba, A, Podolsky, R. and Schuster, G. S. (2006) Protective role of green tea in Sjogren's Syndrome animal models. J. Dental Res. Special Issue, in press
  54. Huang, M. X., Zhang, L. and Shi, K. X. (1985) The epidemiology of systemic lupus erythematosus in Shanghai. Zhonghua Nei Ke Za Zhi. 24, 451-453
  55. Ikebe, K., Nokubi, T., Sajima, H., Kobayashi, S., Hata, K., Ono, T., Ettinger, R. L. (2001) Perception of dry mouth in a sample of community-dwelling older adults in Japan. Spec Care Dentist. 21, 52-59 https://doi.org/10.1111/j.1754-4505.2001.tb00225.x
  56. Imai, K., Suga, K. and Nakachi, K. (1997) Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 26, 769-775 https://doi.org/10.1006/pmed.1997.0242
  57. Imai, K. and Nakachi, K. (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ. 310, 693-696 https://doi.org/10.1136/bmj.310.6981.693
  58. Kanauchi, H., Imamura, S., Takigawa, M. and Furukawa, F. (1994) Evaluation of the Japanese-Chinese herbal medicine, kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. J. Dermatol. 21, 935-939 https://doi.org/10.1111/j.1346-8138.1994.tb03315.x
  59. Kang, H. I., Fei, H. M., Saito, I., Sawada, S., Chen, S. L., Yi, D., Chan, E., Peebles, C., Bugawan, T. L. and Erlich, H. A. (1993) Comparison of HLA class II genes in caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J. Immunol. 150, 3615-3623
  60. Kassan, S. S. and Moutsopoulos, H. M. (2004) Clinical manifestations and early diagnosis of Sjögren's syndrome. Arch. Inter. Med. 164, 1275-1284 https://doi.org/10.1001/archinte.164.12.1275
  61. Katiyar, S. K. and Elmets, C. A. (2001) Green tea polyphenolic antioxidants and skin photoprotection. Int. J. Oncol. 18, 1307- 1313
  62. Khurshudian, A. V. (2003) A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 95, 38-44 https://doi.org/10.1067/moe.2003.30
  63. Klimpel, G. R., Infante, A. J., Patterson, J., Hess, C. B. and Asuncion, M. (1990) Virus-induced interferon alpha/beta (IFNalpha/ beta) production by T cells and by Th1 and Th2 helper T cell clones: a study of the immunoregulatory actions of IFNgamma versus IFN-alpha/beta on functions of different T cell populations. Cell Immunol. 128, 603-618 https://doi.org/10.1016/0008-8749(90)90052-S
  64. Kuhn, A., Herrmann, M., Kleber, S., Beckmann-Welle, M., Fehsel, K., Martin-Villalba, A., Lehmann, P., Ruzicka, T., Krammer, P. H. and Kolb-Bachofen, V. (2006) Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum. 54, 939-950 https://doi.org/10.1002/art.21658
  65. Kuroda, Y. and Hara, Y. (1999) Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res. 436, 69-97 https://doi.org/10.1016/S1383-5742(98)00019-2
  66. Lawley, W., Doherty, A., Denniss, S., Chauhan, D., Pruijn, G., van Venrooij, W. J., Lunec, J. and Herbert, K. (2000) Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes. Rheumatology (Oxford) 39, 253-261 https://doi.org/10.1093/rheumatology/39.3.253
  67. Li, D., Lin, H. H., McMahon, M., Ma, H. and Ann, D. K. (1997) Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells. J. Biol. Chem. 272, 25062-25070 https://doi.org/10.1074/jbc.272.40.25062
  68. Mahoney, E. J. and Spiegel, J. H. (2003) Sjögren's disease. Otolaryngol. Clin. North Am. 36, 733-745 https://doi.org/10.1016/S0030-6665(03)00024-0
  69. Mamula, M. J., Fatenejad, S. and Craft, J. (1994) B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152, 1453-1461
  70. Mikuls, T. R., Cerhan, J. R., Criswell, L. A., Merlino, L., Mudano, A. S., Burma, M., Folsom, A. R. and Saag, K. G. (2002) Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 46, 83-91 https://doi.org/10.1002/1529-0131(200201)46:1<83::AID-ART10042>3.0.CO;2-D
  71. Millard, T. P., Hawk, J. L. M. and McGregor, J. M. (2000) Photosensitivity in lupus. Lupus. 9, 3-10 https://doi.org/10.1177/096120330000900103
  72. Miyasaka, N. (1995) Epidemiology and pathogenesis of Sjogren's syndrome. Nippon Rinsho. 53, 2367-2370
  73. Manganelli, P. and Fietta, P. (1993) Apoptosis and Sjögren's syndrome. Semin Arthritis Rheum. 33, 49-65 https://doi.org/10.1053/sarh.2003.50019
  74. Mikuls, T. R., Cerhan, J. R., Criswell, L. A., Merlino, L., Mudano, A. S., Burma, M., Folsom, A. R. and Saag, K. G. (2002) Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 46, 83-91 https://doi.org/10.1002/1529-0131(200201)46:1<83::AID-ART10042>3.0.CO;2-D
  75. Morin, C. I. and Huot, J. (2004) Recent advances in stress signaling in cancer. Cancer Res. 64, 1893-1898 https://doi.org/10.1158/0008-5472.CAN-03-3448
  76. Mukhtar, H. and Ahmad, N. (2000) Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr. 71, 1698- 1702 https://doi.org/10.1093/ajcn/71.6.1698S
  77. Nakamura, H., Kawakami, A., Yamasaki, S., Kawabe, Y., Nakamura, T. and Eguchi, K. (1999) Expression of mitogen activated protein kinases in labial salivary glands of patients with Sjogren's syndrome. Ann. Rheum. Dis. 58, 382-385 https://doi.org/10.1136/ard.58.6.382
  78. Norris, D. A. (1993) Pathomechanisms of photosensitive lupus erythematosus. J. Invest. Dermatol. 100, 58-68 https://doi.org/10.1111/1523-1747.ep12355599
  79. Nozawa, K., Casiano, C. A., Hamel, J. C., Molinaro, C., Fritzler, M. J. and Chan, E. K. (2002) Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Res. 4, 3 https://doi.org/10.1186/ar470
  80. Ohno, S., Suzuki, T. and Dohi, Y. (1990) The effect of bakumondo-to on salivary secretion in Sjogren syndrome. Ryumachi. 30, 10-16
  81. Pablos, J. L., Santiago, B., Galindo, M., Carreira, P. E., Ballestin, C. and Gomez-Reino, J. J. (1999) Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. J. Pathol. 188, 63-68 https://doi.org/10.1002/(SICI)1096-9896(199905)188:1<63::AID-PATH303>3.0.CO;2-E
  82. Porter, S. R., Scully, C. and Hegarty, A. M. (2004) An update of the etiology and management of xerostomia. Oral Surg. Oral Med. Oral. Pathol. Oral. Radiol. Endod. 97, 28-46 https://doi.org/10.1016/j.tripleo.2003.07.010
  83. Ramgolam, V., Ang, S. G., Lai, Y. H., Loh, C. S. and Yap, H. K. (2000) Traditional Chinese medicines as immunosuppressive agents. Ann. Acad. Med. Singapore. 29, 11-16
  84. Reeves, G. E. (2004) Update on the immunology, diagnosis and management of systemic lupus erythematosus. Intern. Med. J. 34, 338-347 https://doi.org/10.1111/j.1444-0903.2004.00578.x
  85. Rehman, H. U. (2003) Sjogren's syndrome. Yonsei Med. J. 44, 947-954 https://doi.org/10.3349/ymj.2003.44.6.947
  86. (2003) Rimary Sjogren's syndrome. J. Med. Invest. 50, 32-38
  87. Risch, N. (2000) Searching for genes in complex diseases: lessons from systemic lupus erythematosus. J. Clin. Invest. 105, 1503- 1506 https://doi.org/10.1172/JCI10266
  88. Rosen, A. and Casciola-Rosen, L. (2004) Altered autoantigen structure in Sjögren's syndrome: implications for the pathogenesis of autoimmune tissue damage. Crit. Rev. Oral. Biol. Med. 15, 156-164 https://doi.org/10.1177/154411130401500304
  89. Sawalha, A. H., Potts, R., Schmid, W. R., Scofield, R. H. and Harley, J. B. (2003) The genetics of primary Sjögren's syndrome. Curr. Rheumatol. Rep. 5, 324-332 https://doi.org/10.1007/s11926-003-0012-x
  90. Sayama, K., Oguni, I., Tsubura, A., Tanaka, S. and Matsuzawa, A. (2003) Inhibitory effects of autoimmune disease by green tea in MRL-Faslprcg/Faslprcg mice. In Vivo. 17, 545-552
  91. Schein, O. D., Hochberg, M. C., Munoz, B., Tielsch, J. M., Bandeen-Roche, K., Provost, T. and Anhalt, G. J. (1999) West S. Dry eye and dry mouth in the elderly: a population-based assessment. Arch. Intern. Med. 159, 1359-1363 https://doi.org/10.1001/archinte.159.12.1359
  92. Singh, R., Ahmed, S., Malemud, C. J., Goldberg, V. M. and Haqqi, T. M. (2003) Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J. Orthop. Res. 21, 102-109 https://doi.org/10.1016/S0736-0266(02)00089-X
  93. Slomiany, B. L. and Slomiany, A. (2002) Porphyromonas gingivalis lipopolysaccharide interferes with salivary mucin synthesis through inducible nitric oxide synthase activation by ERK and p38 kinase. Biochem. Biophys. Res. Commun. 297, 1149-1153 https://doi.org/10.1016/S0006-291X(02)02354-9
  94. Slomiany, B. L. and Slomiany, A. (2002) Nitric oxide interferes with salivary mucin synthesis: involvement of ERK and p38 mitogen-activated protein kinase. Physiol. Pharmacol. 53, 325- 336
  95. Stratton, S. P., Dorr, R. T. and Alberts, D. S. (2000) The state-ofthe- art in chemoprevention of skin cancer. Eur. J. Cancer. 36, 1292-1297 https://doi.org/10.1016/S0959-8049(00)00108-8
  96. Stinton, L. M., Eystathioy, T., Selak, S., Chan, E. K. and Fritzler, M. J. (2004) Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol. 110, 30-44
  97. Sueoka, N., Suganuma, M., Sueoka, E., Okabe, S., Matsuyama, S., Imai, K., Nakachi, K. and Fujiki, H. (2001) A new function of green tea: prevention of lifestyle-related diseases. Ann. NY Acad. Sci. 928, 274-280 https://doi.org/10.1111/j.1749-6632.2001.tb05656.x
  98. Utz, P. J. and Anderson, P. (2000) Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ. 7, 589-602 https://doi.org/10.1038/sj.cdd.4400696
  99. Tan, E. M. (1994) Autoimmunity and apoptosis. J. Exp. Med. 179, 1083-1086 https://doi.org/10.1084/jem.179.4.1083
  100. Vayalil, P. K., Elmets, C. A. and Katiyar, S. K. (2004) Treatment of green tea polyphenols in hydrophilic cream prevents UVBinduced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 24, 927-936 https://doi.org/10.1093/carcin/bgg025
  101. Venables, P. J. (2004) Sjogren's syndrome. Best Pract. Res. Clin. Rheumatol. 18, 313-329
  102. Ventura, A., Magazzu, G. and Greco, L. (1999) Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP study group for autoimmune disorders in celiac disease. Gastroenterology 117, 297-303 https://doi.org/10.1053/gast.1999.0029900297
  103. Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., Pillemer, S. R., Talal, N. and Weisman, M. H. (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554-558 https://doi.org/10.1136/ard.61.6.554
  104. Vescovi, P., Manfredi, M. and Cimarosti, S. (2004) Sjogren's syndrome: clinical and therapeutic features. A review of the literature. Minerva Stomatol. 53, 1-19
  105. Wang, B., Dong, X., Yuan, Z., Zuo, Y. and Wang, J. (1999) SSA/ Ro antigen expressed on membrane of UVB-induced apoptotic keratinocytes is pathogenic but not detectable in supernatant of cell culture. Chin. Med. J. (Engl). 112, 512-515
  106. Wang, Y., Virji, A. S., Howard, P., Sayani, Y., Zhang, J., Achu, P. and McArthur, C. (2006) Detection of cleaved alpha-fodrin autoantigen in Sjogren's syndrome: Apoptosis and colocalisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands. Arch. Oral. Biol. Epub ahead of print
  107. Wenzel, J., Uerlich, M., Haller, O., Bieber, T. and Tüting, T. (2005) Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3 expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod. J. Cutan. Pathol. 32, 257-262 https://doi.org/10.1111/j.0303-6987.2005.00297.x
  108. Werth, V. P., Bashir, M. and Zhang, W. (2004) Photosensitivity in rheumatic diseases. J. Invest. Dermatol. Symp. Proc. 9, 57-63 https://doi.org/10.1111/j.1087-0024.2004.00839.x
  109. Wheeler, D. S., Catravas, J. D., Odoms, K., Denenberg, A., Malhotra, V. and Wong, H. R. (2004) Epigallocatechin-3- gallate, a green tea-derived polyphenol, inhibits IL-1 betadependent proinflammatory signal transduction in cultured respiratory epithelial cells. J. Nutr. 134, 1039-1044 https://doi.org/10.1093/jn/134.5.1039
  110. Yamamoto, K. (2003) Pathogenesis of Sjogren's syndrome. Autoimmun Rev. 2, 13-18 https://doi.org/10.1016/S1568-9972(02)00121-0
  111. Yang, C. S., Lee, M. J. and Chen, L. (1999) Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Cancer Epidemiol. Biomarkers Prev. 8, 83-89
  112. Yang, C. S., Maliakal, P. and Meng, X. (2002) Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42, 25- 54 https://doi.org/10.1146/annurev.pharmtox.42.082101.154309
  113. Yamamoto, T., Hsu, S., Lewis, J., Wataha, J., Dickinson, D., Singh, B., Bollag, W. B., Lockwood, P., Ueta, E., Osaki, T. and Schuster, G. (2003) Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J. Pharmacol. Exp. Ther. 307, 230-236 https://doi.org/10.1124/jpet.103.054676
  114. Yamamoto, T., Staples, J., Wataha, J., Lewis, J., Lockwood, P., Schoenlein, P., Rao, S., Osaki, T., Dickinson, D., Kamatani, T., Schuster, G. and Hsu, S. (2004) Protective effects of EGCG on salivary gland cells treated with gamma-radiation or cisplatinum( II)diammine dichloride. Anticancer Res. 24, 3065- 3073
  115. Yang, F., de Villiers, W. J., McClain, C. J. and Varilek, G. W. (1998) Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr. 128, 2334-2340 https://doi.org/10.1093/jn/128.12.2334
  116. Yoshida, S. (1999) Sjogren's syndrome. Nippon Rinsho. 57, 360- 363
  117. Zhang, N. (1995) Epidemiological study of primary Sjogrne's syndrome in China. Chin. Med. J. Engl. 108, 787-788
  118. Zhao, L. J., Li, Z. J., Huang, Y. Y., Ti, Z. K. and Chen, Y. (1989) Experience on 60 cases of Sjogren's syndrome diagnosed and treated with traditional Chinese medicine. J. Tradit. Chin. Med. 9, 31-34
  119. Zentner, M. D., Lin, H. H., Wen, X., Kim, K. J. and Ann, D. K. (1989) The amiloride-sensitive epithelial sodium channel alphasubunit is transcriptionally down-regulated in rat parotid cells by the extracellular signal-regulated protein kinase pathway. J. Biol. Chem. 273, 30770-30776 https://doi.org/10.1074/jbc.273.46.30770
  120. Zhang, M., Zhang, Y., Wang, L. and Li, F. (2001) Expression of Fas and Fas ligand in lesions of patients with discoid lupus erythematosus. Hua Xi Yi Ke Da Xue Xue Bao. 32, 513-515

피인용 문헌

  1. Trehalose inhibits oral dryness by protecting the cell membrane vol.39, pp.9, 2010, https://doi.org/10.1016/j.ijom.2010.04.047
  2. Salivary gland imaging in Sjogren’s syndrome vol.2, pp.1, 2007, https://doi.org/10.2217/17460816.2.1.83
  3. Epigallocatechin-3-gallate modulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to disease onset vol.45, pp.7, 2012, https://doi.org/10.3109/08916934.2012.710860
  4. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease vol.83, pp.17-18, 2008, https://doi.org/10.1016/j.lfs.2008.08.011
  5. Protective Effect of Epigallocatechin Gallate in Murine Water-Immersion Stress Model of Chronic Fatigue Syndrome vol.106, pp.6, 2010, https://doi.org/10.1111/j.1742-7843.2009.00525.x
  6. Potential Health Benefits of Green Tea (Camellia sinensis): A Narrative Review vol.2, pp.6, 2006, https://doi.org/10.1016/j.explore.2006.08.008
  7. Oral Manifestations of Sjögren’s Syndrome vol.87, pp.4, 2008, https://doi.org/10.1177/154405910808700411
  8. Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-α-induced cytotoxicity vol.40, pp.2, 2007, https://doi.org/10.1080/08916930601167343
  9. Can low dose diagnostic dental radiation trigger Sjögren’s syndrome? vol.69, pp.5, 2007, https://doi.org/10.1016/j.mehy.2007.02.026
  10. Involvement of lymphoid inducer cells in the development of secondary and tertiary lymphoid structure vol.42, pp.4, 2009, https://doi.org/10.5483/BMBRep.2009.42.4.189
  11. Green tea consumption: an alternative approach to managing oral lichen planus vol.61, pp.6, 2012, https://doi.org/10.1007/s00011-012-0440-z